Literature DB >> 12423891

Mulberry anthracnose antagonists (iturins) produced by Bacillus amyloliquefaciens RC-2.

Syuntaro Hiradate1, Shigenobu Yoshida, Hajime Sugie, Hiroshi Yada, Yoshiharu Fujii.   

Abstract

Bacillus amyloliquefaciens strain RC-2 produced seven antifungal compounds (1-7) secreted into the culture filtrate. These compounds inhibited the development of mulberry anthracnose caused by the fungus, Colletotrichum dematium. Chemical structural analyses by NMR and FAB-MS revealed that all these compounds were iturins (cyclic peptides with the following sequence: L-Asn --> D-Tyr --> D-Asn --> L-Gln --> L-Pro --> D-Asn --> L-Ser --> D-beta-amino acid -->) and compounds 1-6 are identical to iturins A-2-A-7, respectively. Compound 7 (iturin A-8) is a new iturin, which has a -(CH(2))(10)CH(CH(3))CH(2)CH(3) group as a side chain in the beta-amino acid in the molecule.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12423891     DOI: 10.1016/s0031-9422(02)00365-5

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  16 in total

1.  Production of lipopeptides among Bacillus strains showing growth inhibition of phytopathogenic fungi.

Authors:  R V Velho; L F C Medina; J Segalin; A Brandelli
Journal:  Folia Microbiol (Praha)       Date:  2011-08-05       Impact factor: 2.099

2.  Cyclic lipopeptide profile of three Bacillus subtilis strains; antagonists of Fusarium head blight.

Authors:  Christopher A Dunlap; David A Schisler; Neil P Price; Steven F Vaughn
Journal:  J Microbiol       Date:  2011-09-02       Impact factor: 3.422

3.  Bacillus subtilis subsp. subtilis CBMDC3f with antimicrobial activity against Gram-positive foodborne pathogenic bacteria: UV-MALDI-TOF MS analysis of its bioactive compounds.

Authors:  M J Torres; G Petroselli; M Daz; R Erra-Balsells; M C Audisio
Journal:  World J Microbiol Biotechnol       Date:  2015-03-29       Impact factor: 3.312

4.  Isolation and characterization of antifungal peptides produced by Bacillus amyloliquefaciens LBM5006.

Authors:  Lisianne Brittes Benitez; Renata Voltolini Velho; Marcia Pagno Lisboa; Luis Fernando da Costa Medina; Adriano Brandelli
Journal:  J Microbiol       Date:  2011-01-09       Impact factor: 3.422

5.  Bacillus sp.: A Remarkable Source of Bioactive Lipopeptides.

Authors:  A Théatre; A C R Hoste; A Rigolet; I Benneceur; M Bechet; M Ongena; M Deleu; P Jacques
Journal:  Adv Biochem Eng Biotechnol       Date:  2022       Impact factor: 2.635

6.  Novel Isoindolinone-Based Analogs of the Natural Cyclic Peptide Fenestin A: Synthesis and Antitumor Activity.

Authors:  Huanli Zhang; Jingwan Wu; Jingchun Wang; Shimei Xiao; Lei Zhao; Rui Yan; Xiaodan Wu; Zhiqiang Wang; Li Fan; Yingxue Jin
Journal:  ACS Med Chem Lett       Date:  2022-06-29       Impact factor: 4.632

7.  Arenamides A-C, cytotoxic NFkappaB inhibitors from the marine actinomycete Salinispora arenicola.

Authors:  Ratnakar N Asolkar; Kelle C Freel; Paul R Jensen; William Fenical; Tamara P Kondratyuk; Eun-Jung Park; John M Pezzuto
Journal:  J Nat Prod       Date:  2009-03-27       Impact factor: 4.050

8.  Both extracellular chitinase and a new cyclic lipopeptide, chromobactomycin, contribute to the biocontrol activity of Chromobacterium sp. C61.

Authors:  Hyun Jung Kim; Ho Seong Choi; Si Young Yang; In Seon Kim; Tokutaro Yamaguchi; Jae Kyung Sohng; Seuk Kee Park; Jin-Cheol Kim; Choong Hwan Lee; Brian McSpadden Gardener; Young Cheol Kim
Journal:  Mol Plant Pathol       Date:  2013-09-11       Impact factor: 5.663

9.  Preparation of Nanomaterial Wettable Powder Formulations of Antagonistic Bacteria from Phellodendron chinense and the Biological Control of Brown Leaf Spot Disease.

Authors:  Yanling Zeng; Han Liu; Tianhui Zhu; Shan Han; Shujiang Li
Journal:  Plant Pathol J       Date:  2021-06-01       Impact factor: 1.795

10.  Evaluation of a lipopeptide biosurfactant from Bacillus natto TK-1 as a potential source of anti-adhesive, antimicrobial and antitumor activities.

Authors:  Xiao-Hong Cao; Zhen-Yu Liao; Chun-Ling Wang; Wen-Yan Yang; Mei-Fang Lu
Journal:  Braz J Microbiol       Date:  2009-06-01       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.